Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of$ 0.09. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -88.89%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of$ 0.08 per share when it actually produced a loss of $0.12, delivering a surprise of -50%.Over the last four ...